Literature DB >> 33093167

Autofluorescence Imaging of 3D Tumor-Macrophage Microscale Cultures Resolves Spatial and Temporal Dynamics of Macrophage Metabolism.

Tiffany M Heaster1,2, Mouhita Humayun1, Jiaquan Yu1,3, David J Beebe1,4,5, Melissa C Skala6,2,4.   

Abstract

Macrophages within the tumor microenvironment (TME) exhibit a spectrum of protumor and antitumor functions, yet it is unclear how the TME regulates this macrophage heterogeneity. Standard methods to measure macrophage heterogeneity require destructive processing, limiting spatiotemporal studies of function within the live, intact 3D TME. Here, we demonstrate two-photon autofluorescence imaging of NAD(P)H and FAD to nondestructively resolve spatiotemporal metabolic heterogeneity of individual macrophages within 3D microscale TME models. Fluorescence lifetimes and intensities of NAD(P)H and FAD were acquired at 24, 48, and 72 hours poststimulation for mouse macrophages (RAW264.7) stimulated with IFNγ or IL4 plus IL13 in 2D culture, confirming that autofluorescence measurements capture known metabolic phenotypes. To quantify metabolic dynamics of macrophages within the TME, mouse macrophages or human monocytes (RAW264.7 or THP-1) were cultured alone or with breast cancer cells (mouse polyoma-middle T virus or primary human IDC) in 3D microfluidic platforms. Human monocytes and mouse macrophages in tumor cocultures exhibited significantly different FAD mean lifetimes and greater migration than monocultures at 24, 48, and 72 hours postseeding. In cocultures with primary human cancer cells, actively migrating monocyte-derived macrophages had greater redox ratios [NAD(P)H/FAD intensity] compared with passively migrating monocytes at 24 and 48 hours postseeding, reflecting metabolic heterogeneity in this subpopulation of monocytes. Genetic analyses further confirmed this metabolic heterogeneity. These results establish label-free autofluorescence imaging to quantify dynamic metabolism, polarization, and migration of macrophages at single-cell resolution within 3D microscale models. This combined culture and imaging system provides unique insights into spatiotemporal tumor-immune cross-talk within the 3D TME. SIGNIFICANCE: Label-free metabolic imaging and microscale culture technologies enable monitoring of single-cell macrophage metabolism, migration, and function in the 3D tumor microenvironment. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33093167      PMCID: PMC7718391          DOI: 10.1158/0008-5472.CAN-20-0831

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  61 in total

Review 1.  Macrophages and Metabolism in the Tumor Microenvironment.

Authors:  Ilio Vitale; Gwenola Manic; Lisa M Coussens; Guido Kroemer; Lorenzo Galluzzi
Journal:  Cell Metab       Date:  2019-07-02       Impact factor: 27.287

2.  Reconfigurable open microfluidics for studying the spatiotemporal dynamics of paracrine signalling.

Authors:  Jiaquan Yu; Erwin Berthier; Alexandria Craig; Theodorus E de Groot; Sidney Sparks; Patrick N Ingram; David F Jarrard; Wei Huang; David J Beebe; Ashleigh B Theberge
Journal:  Nat Biomed Eng       Date:  2019-08-19       Impact factor: 25.671

Review 3.  Macrophage Polarization.

Authors:  Peter J Murray
Journal:  Annu Rev Physiol       Date:  2016-10-21       Impact factor: 19.318

4.  Macrophage interactions with polylactic acid and chitosan scaffolds lead to improved recruitment of human mesenchymal stem/stromal cells: a comprehensive study with different immune cells.

Authors:  Hugo R Caires; Tiago Esteves; Pedro Quelhas; Mário A Barbosa; Melba Navarro; Catarina R Almeida
Journal:  J R Soc Interface       Date:  2016-09       Impact factor: 4.118

5.  Inflammatory Breast Cancer Promotes Development of M2 Tumor-Associated Macrophages and Cancer Mesenchymal Cells through a Complex Chemokine Network.

Authors:  Amanda Valeta-Magara; Abhilash Gadi; Viviana Volta; Beth Walters; Rezina Arju; Shah Giashuddin; Hua Zhong; Robert J Schneider
Journal:  Cancer Res       Date:  2019-05-01       Impact factor: 12.701

6.  Macrophage-Released Pyrimidines Inhibit Gemcitabine Therapy in Pancreatic Cancer.

Authors:  Christopher J Halbrook; Corbin Pontious; Ilya Kovalenko; Laura Lapienyte; Stephan Dreyer; Ho-Joon Lee; Galloway Thurston; Yaqing Zhang; Jenny Lazarus; Peter Sajjakulnukit; Hanna S Hong; Daniel M Kremer; Barbara S Nelson; Samantha Kemp; Li Zhang; David Chang; Andrew Biankin; Jiaqi Shi; Timothy L Frankel; Howard C Crawford; Jennifer P Morton; Marina Pasca di Magliano; Costas A Lyssiotis
Journal:  Cell Metab       Date:  2019-02-28       Impact factor: 27.287

7.  Identification of a common gene signature for type II cytokine-associated myeloid cells elicited in vivo in different pathologic conditions.

Authors:  Gholamreza Hassanzadeh Ghassabeh; Patrick De Baetselier; Lea Brys; Wim Noël; Jo A Van Ginderachter; Sofie Meerschaut; Alain Beschin; Frank Brombacher; Geert Raes
Journal:  Blood       Date:  2006-03-23       Impact factor: 22.113

Review 8.  Discovering Macrophage Functions Using In Vivo Optical Imaging Techniques.

Authors:  Yue Li; Tzu-Ming Liu
Journal:  Front Immunol       Date:  2018-03-15       Impact factor: 7.561

Review 9.  The M1 and M2 paradigm of macrophage activation: time for reassessment.

Authors:  Fernando O Martinez; Siamon Gordon
Journal:  F1000Prime Rep       Date:  2014-03-03

Review 10.  Metabolic reprograming in macrophage polarization.

Authors:  Silvia Galván-Peña; Luke A J O'Neill
Journal:  Front Immunol       Date:  2014-09-02       Impact factor: 7.561

View more
  4 in total

1.  Breast cancer immunotherapy: current biomarkers and the potential of in vitro assays.

Authors:  Melissa C Skala; Jose M Ayuso; Mark E Burkard; Dustin A Deming
Journal:  Curr Opin Biomed Eng       Date:  2021-09-20

2.  Luminescence lifetime imaging of three-dimensional biological objects.

Authors:  Ruslan I Dmitriev; Xavier Intes; Margarida M Barroso
Journal:  J Cell Sci       Date:  2021-05-07       Impact factor: 5.285

3.  A bioengineered organotypic prostate model for the study of tumor microenvironment-induced immune cell activation.

Authors:  Sheena C Kerr; Molly M Morgan; Amani A Gillette; Megan K Livingston; Karina M Lugo-Cintron; Peter F Favreau; Logan Florek; Brian P Johnson; Joshua M Lang; Melissa C Skala; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2020-10-16       Impact factor: 3.177

4.  Interactions with stromal cells promote a more oxidized cancer cell redox state in pancreatic tumors.

Authors:  Rupsa Datta; Sharanya Sivanand; Allison N Lau; Logan V Florek; Anna M Barbeau; Jeffrey Wyckoff; Melissa C Skala; Matthew G Vander Heiden
Journal:  Sci Adv       Date:  2022-01-21       Impact factor: 14.136

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.